Press Releases :: IceCure Medical Ltd. (ICCM)

Skip to main content Skip to section navigation Skip to footer

Aug 05, 2019 8:00 am EDT

Another Success: IceCure Receives Israeli AMAR Approval for Use of its Freezing Technology in Specific Indications, Following an Earlier General Approval

Jul 02, 2019 8:00 am EDT

IceCure Medical Announces New Category III CPT Code for Breast Cryoablation Therapy, Issued by the American Medical Association

Mar 20, 2019 8:00 am EDT

IceCure Medical Presents Promising Results from First-ever Interventional Radiology Study With Its Next Generation Liquid Nitrogen (LN2) Cryoablation System, ProSense™

Feb 05, 2019 7:30 am EST

Recent American Society of Breast Surgeons (ASBrS) Guidelines are Favorable to Next Generation Cryoablation Developer, IceCure Medical

May 01, 2014 4:08 pm EDT

IceCure Medical, Inc. announces commencement of ICE3 clinical trial for breast cancer

Nov 08, 2013 1:00 pm EST

IceCure Medical Ltd. announces treatment of first breast cancer patient using its IceSense3 Cryoablation System at John Wayne Cancer Institute

May 07, 2013 5:10 pm EDT

Use Of Cryoablation For Treatment Of Breast Cancer Shows Promising Results

Jun 04, 2012 11:28 am EDT

First Breast Cancer Patients Treated With Minimally Invasive IceSense3 Cryoablation Procedure

Select a page:

rss_feed News RSS

IceCure Medical HQ: 7 Ha’Eshel St., PO Box 3163, Caesarea, 3079504, Israel

© 2025 All Rights Reserved IceCure Medical

Branding by

Terms of Use | Privacy | Last Updated: April 9, 2023